ZA96299B - Tricyclic benzazepine vasopressin antagonists - Google Patents

Tricyclic benzazepine vasopressin antagonists

Info

Publication number
ZA96299B
ZA96299B ZA96299A ZA96299A ZA96299B ZA 96299 B ZA96299 B ZA 96299B ZA 96299 A ZA96299 A ZA 96299A ZA 96299 A ZA96299 A ZA 96299A ZA 96299 B ZA96299 B ZA 96299B
Authority
ZA
South Africa
Prior art keywords
vasopressin antagonists
tricyclic benzazepine
benzazepine vasopressin
tricyclic
antagonists
Prior art date
Application number
ZA96299A
Other languages
English (en)
Inventor
Jay D Albright
Xuemei Du
Aranapakam M Venkatesan
Santos Efren G Delos
Marvin F Reich
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA96299B publication Critical patent/ZA96299B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA96299A 1995-01-17 1996-01-15 Tricyclic benzazepine vasopressin antagonists ZA96299B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/373,139 US5532235A (en) 1995-01-17 1995-01-17 Tricyclic benzazepine vasopressin antagonists

Publications (1)

Publication Number Publication Date
ZA96299B true ZA96299B (en) 1997-07-15

Family

ID=23471147

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA96299A ZA96299B (en) 1995-01-17 1996-01-15 Tricyclic benzazepine vasopressin antagonists

Country Status (21)

Country Link
US (2) US5532235A (cs)
EP (1) EP0804440B1 (cs)
JP (1) JP4219978B2 (cs)
CN (1) CN1061658C (cs)
AR (1) AR002268A1 (cs)
AT (1) ATE381570T1 (cs)
AU (1) AU4775596A (cs)
BR (1) BR9607186B1 (cs)
CA (1) CA2210632A1 (cs)
CZ (1) CZ224897A3 (cs)
DE (1) DE69637369T2 (cs)
DK (1) DK0804440T3 (cs)
EA (1) EA000607B1 (cs)
ES (1) ES2297835T3 (cs)
HU (1) HUP9702219A3 (cs)
IL (1) IL116773A (cs)
MX (1) MX9705415A (cs)
NZ (1) NZ302159A (cs)
TW (1) TW426684B (cs)
WO (1) WO1996022295A1 (cs)
ZA (1) ZA96299B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532235A (en) * 1995-01-17 1996-07-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
AU7338796A (en) * 1995-11-09 1997-05-29 Japan Tobacco Inc. Five-membered fused heterocyclic azepine derivatives and pharmaceutical use thereof
JP2791430B2 (ja) 1995-11-09 1998-08-27 日本たばこ産業株式会社 縮合ヘテロ５員環アゼピン誘導体及びその医薬用途
US5880122A (en) * 1996-11-01 1999-03-09 American Home Products Corporation 3-Carboxamide derivatives of 5H-pyrrolo 2,1-c! 1,4!-benzodiazepines
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
US6235900B1 (en) 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US7109193B2 (en) 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
US6977254B2 (en) * 2001-04-12 2005-12-20 Wyeth Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7202239B2 (en) * 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
JP2004526771A (ja) * 2001-04-12 2004-09-02 ワイス シクロヘキシルフェニルバソプレッシンアゴニスト
US6903091B2 (en) 2001-04-12 2005-06-07 Wyeth Biphenyl vasopressin agonists
US6900200B2 (en) 2001-04-12 2005-05-31 Wyeth Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7326700B2 (en) * 2001-04-12 2008-02-05 Wyeth Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US7064120B2 (en) * 2001-04-12 2006-06-20 Wyeth Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
US7057046B2 (en) * 2002-05-20 2006-06-06 Bristol-Myers Squibb Company Lactam glycogen phosphorylase inhibitors and method of use
US7098235B2 (en) 2002-11-14 2006-08-29 Bristol-Myers Squibb Co. Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
JP2008513140A (ja) * 2004-09-17 2008-05-01 コーディス・ニューロバスキュラー・インコーポレイテッド 血管の一時的または永続的閉塞のための薄膜器具
CA2614746C (en) 2005-07-09 2011-05-10 Astrazeneca Ab Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
JP5909441B2 (ja) 2010-04-05 2016-04-26 塩野義製薬株式会社 カテコール基を有するセフェム化合物
US20200325140A1 (en) * 2016-05-25 2020-10-15 Akarna Therapeutics, Ltd. Fused bicyclic compounds for the treatment of disease
US10647661B2 (en) 2017-07-11 2020-05-12 Vertex Pharmaceuticals Incorporated Carboxamides as modulators of sodium channels
WO2020146682A1 (en) 2019-01-10 2020-07-16 Vertex Pharmaceuticals Incorporated Carboxamides as modulators of sodium channels
US12440481B2 (en) 2019-01-10 2025-10-14 Vertex Pharmaceuticals Incorporated Esters and carbamates as modulators of sodium channels
KR20230152111A (ko) * 2021-03-05 2023-11-02 상하이 제민케어 파마슈티칼 컴퍼니 리미티드 신규 벤자제핀 융합 고리 유도체
CN119604507A (zh) * 2022-09-05 2025-03-11 上海济煜医药科技有限公司 苯并氮杂卓并环化合物盐型、晶型及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766108A (en) * 1986-12-04 1988-08-23 Smith Kline Beckman Corporation Tyr-Arg-vasopressin antagonists
US5055448A (en) * 1987-06-25 1991-10-08 Medical College Of Ohio Linear derivatives of arginine vasopressin antagonists
ES2056259T3 (es) * 1989-02-10 1994-10-01 Otsuka Pharma Co Ltd Derivados de carboestirilo.
EP0450097B1 (en) * 1989-10-20 1996-04-24 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
US5070187A (en) * 1989-11-03 1991-12-03 Trustees Of Boston University Pharmacologically effective antagonists of arginine-vasopressin
TW199153B (cs) * 1990-08-07 1993-02-01 Dtsuka Seiyaku Kk
CA2066104C (en) * 1991-04-19 2003-05-27 Hidenori Ogawa Benzazepine derivatives as vasopressin antagonists
EP0533243B1 (en) * 1991-09-16 1997-12-17 Merck & Co. Inc. Hydantoin and succinimide-substituted spiroindanylcamphorsulfonyl derivatives
US5204349A (en) * 1991-09-16 1993-04-20 Merck & Co., Inc. Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
EP0533240A3 (en) * 1991-09-16 1993-09-29 Merck & Co. Inc. Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
EP0533242A3 (en) * 1991-09-16 1993-09-15 Merck & Co. Inc. Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
EP0612319A1 (en) * 1992-08-20 1994-08-31 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds as oxytocin and vasopressin antagonists
WO1994012476A1 (fr) * 1992-11-25 1994-06-09 Yamanouchi Pharmaceutical Co., Ltd. Derive de benzanilide
WO1994014796A1 (fr) * 1992-12-21 1994-07-07 Yamanouchi Pharmaceutical Co., Ltd. Nouveau derive de n-(pyridylcarbonyl)benzazepine et son intermediaire
AU6219994A (en) * 1993-03-11 1994-09-26 Yamanouchi Pharmaceutical Co., Ltd. Compound with vasopressin antagonism
GB9307527D0 (en) * 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
US5512563A (en) * 1993-07-29 1996-04-30 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5532235A (en) * 1995-01-17 1996-07-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists

Also Published As

Publication number Publication date
CN1181084A (zh) 1998-05-06
NZ302159A (en) 2000-01-28
MX9705415A (es) 1997-11-29
US5532235A (en) 1996-07-02
WO1996022295A1 (en) 1996-07-25
BR9607186A (pt) 1997-11-11
TW426684B (en) 2001-03-21
EA000607B1 (ru) 1999-12-29
JP4219978B2 (ja) 2009-02-04
AU4775596A (en) 1996-08-07
EP0804440A1 (en) 1997-11-05
ES2297835T3 (es) 2008-05-01
AR002268A1 (es) 1998-03-11
US5719278A (en) 1998-02-17
DE69637369T2 (de) 2009-01-22
CZ224897A3 (cs) 1998-04-15
EA199700111A1 (ru) 1997-12-30
EP0804440B1 (en) 2007-12-19
DK0804440T3 (da) 2008-03-31
CN1061658C (zh) 2001-02-07
HUP9702219A2 (hu) 1998-07-28
CA2210632A1 (en) 1996-07-25
ATE381570T1 (de) 2008-01-15
JPH10512867A (ja) 1998-12-08
HUP9702219A3 (en) 1999-05-28
IL116773A0 (en) 1996-05-14
DE69637369D1 (de) 2008-01-31
IL116773A (en) 2000-12-06
BR9607186B1 (pt) 2009-01-13

Similar Documents

Publication Publication Date Title
ZA96297B (en) Tricyclic benzazepine vasopressin antagonists
ZA96303B (en) Tricyclic benzazepine vasopressin antagonists
ZA96300B (en) Tricyclic benzazepine vasopressin antagonists
ZA96299B (en) Tricyclic benzazepine vasopressin antagonists
IL127470A0 (en) Tricyclic benzazepine vasopressin antagonists
IL116777A0 (en) Tricyclic benzazepine vasopressin antagonists and their preparation
ZA96298B (en) Tricyclic benzazepine vasopressin antagonists
IL133788A0 (en) Tricyclic vasopressin agonists
FI943542L (fi) Trisyklisiä bentsatsepiineja, jotka ovat vasopressiiniantagonisteja
IL144270A0 (en) Tricyclic benzodiazepines as vasopressin receptor antagonists
HU9601176D0 (en) Adhesion-receptor antagonists
AU5844896A (en) Tricyclic diazepines useful as gnrh receptor antagonists
AU3641497A (en) Tricyclic benzazepine vasopressin antagonists
AU3296597A (en) Tricyclic benzazepine vasopressin antagonists
IL118299A0 (en) Pharmacological use of AII-receptor antagonists
AU3296497A (en) Tricyclic benzazepine vasopressin antagonists
SI0804438T1 (sl) Triciklicni benzazepinski antagonisti vazopresina
HK1003892A (en) Tricyclic benzazepine vasopressin antagonists
HK1002959A (en) Tricyclic benzazepine vasopressin antagonists
HK1019448A (en) Tricyclic benzazepine vasopressin antagonists
HK1003264A (en) Bicyclic benzazepine derivatives as vasopressin antagonists
HK1018057B (en) Tricyclic benzazepine compounds
GB9525365D0 (en) Benzazepine derivatives
GB9525388D0 (en) Benzazepine derivatives
ZA961293B (en) Muscarinic antagonists